Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-08

Clinical Trial Update: Safety and Efficacy of UC-MSCs in Patients With Psoriasis Vulgaris [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update examining the safety and efficacy of umbilical cord mesenchymal stem cells (UC-MSCs) in patients with psoriasis vulgaris. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UC-MSCs (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Psoriasis Vulgaris | Phase 1, Phase 2 | Status: UNKNOWN